Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Keith Ridge to step down as chief pharmaceutical officer

After 16 years in the position, Keith Ridge, England's chief pharmaceutical officer (CPhO), will step down in February 2022.

The chief advisor on pharmacy and the use of medications, as well as the head of the pharmacy profession, Ridge has over the years played a leading role on issues such as medicines optimisation, digital medicines and pharmacy educational reform.


Ridge began his training at the University of London’s School of Pharmacy, spending his early years as a registered pharmacist in clinical practice and the pharmaceutical industry. While serving as the chief pharmacist for NHS hospital services in North Glasgow, he restructured the pharmacy service across eleven hospitals in the area, and established and led the cancer pharmacy group for the West of Scotland.

Subsequently, he was recruited by University Hospitals Birmingham Foundation Trust to design an automated system for controlling medicine supply at a brand new hospital.

He has been instrumental in establishing the National Institute for Health and Clinical Excellence, which was later renamed as National Institute for Health and Care Excellence, and the General Pharmaceutical Council. Ridge has also been the driving force behind the ‘healthy living’ pharmacy.

NHS England and Improvement has invited applications from senior pharmacy leaders registered with the General Pharmaceutical Council, with a masters degree in pharmacy (or equivalent) and a postgraduate or management qualification, or equivalent experience to apply for the top pharmacist role in the country- Chief Pharmaceutical Officer for England.

Candidates with demonstrated excellent knowledge and experience of working in or with the Department of Health and Social Care, the NHS, and other health organisations can apply till August 19 for the post.

More For You

Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less